Filing Details

Accession Number:
0001179110-13-002965
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-19 16:06:23
Reporting Period:
2013-02-14
Filing Date:
2013-02-19
Accepted Time:
2013-02-19 16:06:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1318459 Michael Paul Antinori 8 Sylvan Way
Parsippany NJ 07054
Sr. Vp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-14 6,000 $27.81 52,038 No 4 M Direct
Common Stock Disposition 2013-02-14 6,000 $30.90 46,038 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2013-02-14 6,000 $0.00 6,000 $27.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-12-19 No 4 M Direct
Footnotes
  1. The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Antinori on August 10, 2012.
  2. As of 2/14/2013, the original grant (6,000 shares granted on 12/19/2003) was fully vested. After the exercise of the options reported hereby, as of 2/14/2013, all shares covered by this option have been exercised.